Cargando…

Post-intensive care screening: French translation and validation of the Healthy Aging Brain Care-Monitor, hybrid version

BACKGROUND: The Healthy Aging Brain Care-Monitor (HABC-M) questionnaires (self-reported version and caregiver version) have been validated for post-intensive care syndrome (PICS) detection in patients surviving a stay in the intensive care unit (ICU). Their authors have also developed a hybrid versi...

Descripción completa

Detalles Bibliográficos
Autores principales: Horlait, Geoffrey, Beaudart, Charlotte, Bougard, Laurine, Bornheim, Stephen, Colson, Camille, Misset, Benoit, Bruyère, Olivier, Boustani, Malaz, Rousseau, Anne-Françoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976274/
https://www.ncbi.nlm.nih.gov/pubmed/35366901
http://dx.doi.org/10.1186/s12955-022-01967-1
_version_ 1784680531896565760
author Horlait, Geoffrey
Beaudart, Charlotte
Bougard, Laurine
Bornheim, Stephen
Colson, Camille
Misset, Benoit
Bruyère, Olivier
Boustani, Malaz
Rousseau, Anne-Françoise
author_facet Horlait, Geoffrey
Beaudart, Charlotte
Bougard, Laurine
Bornheim, Stephen
Colson, Camille
Misset, Benoit
Bruyère, Olivier
Boustani, Malaz
Rousseau, Anne-Françoise
author_sort Horlait, Geoffrey
collection PubMed
description BACKGROUND: The Healthy Aging Brain Care-Monitor (HABC-M) questionnaires (self-reported version and caregiver version) have been validated for post-intensive care syndrome (PICS) detection in patients surviving a stay in the intensive care unit (ICU). Their authors have also developed a hybrid version (HABC-M-HV) suited to the daily needs of their post-ICU follow-up clinic. The objectives of the present cross-sectional observational study were to translate the HABC-M-HV questionnaire into French (HABC-M-HV-F) according to international guidelines and to test its measurement properties. METHODS: The HABC-M-HV was translated according to international guidelines. The measurement performances of the questionnaire were tested using internal consistency, test–retest reliability, Standard Error of Measurement (SEM) and Smallest Detectable Change (SDC) calculation, floor and ceiling effect measurement and construct validity. RESULTS: The validation study included 51 ICU survivors (27.5% women, 63 [55–71] years old). The questionnaire was administered by phone. The internal consistency was very good (Cronbach’s alpha coefficient 0.79). The intra- and inter-examinator reliabilities were excellent (Intraclass Coefficient Correlation = 0.99 and 0.97, respectively). The SEM was 0.62 and the SDC was 1.72. No floor or ceiling effects were observed. The convergent validity was almost entirely confirmed with 71.4% of our hypothesis confirmed. CONCLUSION: The HABC-M-HV-F has been shown to be a valid and reliable tool for PICS screening and follow-up in French-speaking ICU survivors. A remote administration by phone was feasible. Trial registration: Not applicable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-022-01967-1.
format Online
Article
Text
id pubmed-8976274
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89762742022-04-04 Post-intensive care screening: French translation and validation of the Healthy Aging Brain Care-Monitor, hybrid version Horlait, Geoffrey Beaudart, Charlotte Bougard, Laurine Bornheim, Stephen Colson, Camille Misset, Benoit Bruyère, Olivier Boustani, Malaz Rousseau, Anne-Françoise Health Qual Life Outcomes Research BACKGROUND: The Healthy Aging Brain Care-Monitor (HABC-M) questionnaires (self-reported version and caregiver version) have been validated for post-intensive care syndrome (PICS) detection in patients surviving a stay in the intensive care unit (ICU). Their authors have also developed a hybrid version (HABC-M-HV) suited to the daily needs of their post-ICU follow-up clinic. The objectives of the present cross-sectional observational study were to translate the HABC-M-HV questionnaire into French (HABC-M-HV-F) according to international guidelines and to test its measurement properties. METHODS: The HABC-M-HV was translated according to international guidelines. The measurement performances of the questionnaire were tested using internal consistency, test–retest reliability, Standard Error of Measurement (SEM) and Smallest Detectable Change (SDC) calculation, floor and ceiling effect measurement and construct validity. RESULTS: The validation study included 51 ICU survivors (27.5% women, 63 [55–71] years old). The questionnaire was administered by phone. The internal consistency was very good (Cronbach’s alpha coefficient 0.79). The intra- and inter-examinator reliabilities were excellent (Intraclass Coefficient Correlation = 0.99 and 0.97, respectively). The SEM was 0.62 and the SDC was 1.72. No floor or ceiling effects were observed. The convergent validity was almost entirely confirmed with 71.4% of our hypothesis confirmed. CONCLUSION: The HABC-M-HV-F has been shown to be a valid and reliable tool for PICS screening and follow-up in French-speaking ICU survivors. A remote administration by phone was feasible. Trial registration: Not applicable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-022-01967-1. BioMed Central 2022-04-02 /pmc/articles/PMC8976274/ /pubmed/35366901 http://dx.doi.org/10.1186/s12955-022-01967-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Horlait, Geoffrey
Beaudart, Charlotte
Bougard, Laurine
Bornheim, Stephen
Colson, Camille
Misset, Benoit
Bruyère, Olivier
Boustani, Malaz
Rousseau, Anne-Françoise
Post-intensive care screening: French translation and validation of the Healthy Aging Brain Care-Monitor, hybrid version
title Post-intensive care screening: French translation and validation of the Healthy Aging Brain Care-Monitor, hybrid version
title_full Post-intensive care screening: French translation and validation of the Healthy Aging Brain Care-Monitor, hybrid version
title_fullStr Post-intensive care screening: French translation and validation of the Healthy Aging Brain Care-Monitor, hybrid version
title_full_unstemmed Post-intensive care screening: French translation and validation of the Healthy Aging Brain Care-Monitor, hybrid version
title_short Post-intensive care screening: French translation and validation of the Healthy Aging Brain Care-Monitor, hybrid version
title_sort post-intensive care screening: french translation and validation of the healthy aging brain care-monitor, hybrid version
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976274/
https://www.ncbi.nlm.nih.gov/pubmed/35366901
http://dx.doi.org/10.1186/s12955-022-01967-1
work_keys_str_mv AT horlaitgeoffrey postintensivecarescreeningfrenchtranslationandvalidationofthehealthyagingbraincaremonitorhybridversion
AT beaudartcharlotte postintensivecarescreeningfrenchtranslationandvalidationofthehealthyagingbraincaremonitorhybridversion
AT bougardlaurine postintensivecarescreeningfrenchtranslationandvalidationofthehealthyagingbraincaremonitorhybridversion
AT bornheimstephen postintensivecarescreeningfrenchtranslationandvalidationofthehealthyagingbraincaremonitorhybridversion
AT colsoncamille postintensivecarescreeningfrenchtranslationandvalidationofthehealthyagingbraincaremonitorhybridversion
AT missetbenoit postintensivecarescreeningfrenchtranslationandvalidationofthehealthyagingbraincaremonitorhybridversion
AT bruyereolivier postintensivecarescreeningfrenchtranslationandvalidationofthehealthyagingbraincaremonitorhybridversion
AT boustanimalaz postintensivecarescreeningfrenchtranslationandvalidationofthehealthyagingbraincaremonitorhybridversion
AT rousseauannefrancoise postintensivecarescreeningfrenchtranslationandvalidationofthehealthyagingbraincaremonitorhybridversion